Inhibikase Therapeutics, Inc. (IKT) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Inhibikase Therapeutics, Inc. (IKT) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $272.0M, listed on NASDAQ, employing roughly 35 people, carrying a beta of 0.94 to the broader market. Inhibikase Therapeutics, Inc. Led by Mark T. Iwicki, public since 2020-12-23.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for IKT as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →